Vascular Solutions Financial Ratios

Vascular Solutions Inc -- USA Stock  

USD 56  0.00  0.00%

Use fundamental data analysis to confirm all available indicators of Vascular Solutions Inc to find out if markets are presently mispricing the corporation. We found thirty available drivers for Vascular Solutions Inc which can be compared to its competition. To make sure the equity is not overpriced, please validate all Vascular Solutions fundamentals including its Debt to Equity, and the relationship between Net Income and Number of Employees . Given that Vascular Solutions Inc has Number of Shares Shorted of 982.09 K, we advise you double-check Vascular Solutions Inc current market performance to make sure the company can sustain itself down the road.Use Vascular Solutions to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of Vascular Solutions to be traded at $55.44 in 30 days

Vascular Solutions Inc Valuation Over Time

Enterprise Value

Vascular Solutions Company Summary

Vascular Solutions competes with Edwards Lifesciences, Digirad, and DarioHealth Corp. Vascular Solutions Incs primary solutions include GuideLiner guide extension catheter device for use in complex interventions Pronto extraction catheters for treating acute myocardial infarction vein catheter reprocessing service for the radiofrequency vein ablation catheter and microintroducer kits that are used to gain percutaneous access to the vasculature to perform minimally invasive procedures. Its solutions also comprise hemostatic patches consisting of blood clotting products such as the DStat Dry hemostat a topical thrombinbased pad with a bandage used to control surface bleeding radial access products including the Accumed wrist positioning splints and Vasc Band inflatable compression bands Langston catheter used for the measurement of intravascular pressure gradients primarily to diagnose aortic valve stenosis and DStat Flowable hemostat that is used to control active bleeding. Vascular Solutions Inc sells its solutions through direct sales force and distributor to interventional cardiologists interventional radiologists electrophysiologists and vein specialists. Vascular Solutions Inc. was founded in 1996 and is headquartered in Minneapolis Minnesota.

Vascular Solutions Gross Profit vs Debt to Equity

Vascular Solutions Inc is rated first in gross profit category among related companies. It is rated second in debt to equity category among related companies . The ratio of Gross Profit to Debt to Equity for Vascular Solutions Inc is about  750,381,679 

Vascular Solutions Market Fundamentals

 Change(%) 0.00%
 Change0.00 Price Moved None
< 45% 

Chance of Financial Distress

Vascular Solutions Inc has less than 45 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


Vascular Solutions Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare Vascular Solutions To Peers
Howard Root Co-Founder, CEO and Director
John Erb Independent Chairman of the Board
More Executives

Opportunity Range

January 19, 2018 Opportunity Range